Pharma BD Deal Intelligence
Millennium Pharmaceuticals Inc. / COR Therapeutics Inc.
2001 · Acquisition/Merger · $2.0B · Complete
Announcement Sentiment
63
Positive
Stock-for-stock; 0.9873 Millennium shares per COR share. Brought in Integrilin (eptifibatide) cardiovascular franchise. Closed 2002-02-12.
Key facts
- Announced Dec 06, 2001
- Closed Feb 12, 2002
- Deal value $2.0B
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals